Cargando…
Inhibition of Ubiquitin-Specific Proteases as a Novel Anticancer Therapeutic Strategy
Dysfunction or dysregulation of the ubiquitin proteasome system (UPS) is closely related to tumorigenesis and the development of multiple cancers. Targeting the UPS provides a new anticancer therapeutic strategy, but clinically available UPS-targeted inhibitors, including lenalidomide and bortezomib...
Autores principales: | Yuan, Tao, Yan, Fangjie, Ying, Meidan, Cao, Ji, He, Qiaojun, Zhu, Hong, Yang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171565/ https://www.ncbi.nlm.nih.gov/pubmed/30319415 http://dx.doi.org/10.3389/fphar.2018.01080 |
Ejemplares similares
-
The Role of Membrane-Associated E3 Ubiquitin Ligases in Cancer
por: Chen, Xuankun, et al.
Publicado: (2022) -
Phosphorylation regulates cullin-based ubiquitination in tumorigenesis
por: Chen, Yifan, et al.
Publicado: (2021) -
Machado-Joseph Deubiquitinases: From Cellular Functions to Potential Therapy Targets
por: Zeng, Chenming, et al.
Publicado: (2020) -
Targeting Ubiquitin-Specific Protease 7 (USP7) in Cancer: A New Insight to Overcome Drug Resistance
por: Lu, Jiabin, et al.
Publicado: (2021) -
Targeting Myc Interacting Proteins as a Winding Path in Cancer Therapy
por: Zhou, Yihui, et al.
Publicado: (2021)